Chimeric proteins, including bispecific antibodies, are biological tools with therapeutic applications. Genetic fusion and ligation methods allow the creation of N-to-C and C-to-N fused recombinant proteins, but not unnaturally linked N-to-N and C-to-C fusion proteins. This protocol describes a simple procedure for the production of such chimeric proteins, starting from correctly folded proteins and readily available peptides. By equipping the N terminus or C terminus of the proteins of interest with a set of click handles using sortase A, followed by a strain-promoted click reaction, unnatural N-to-N and C-to-C linked (hetero) fusion proteins are established. Examples of proteins that have been conjugated via this method include interleuki...
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical ...
For more than a century, filamentous fungi have been used for the production of a wide variety of en...
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy...
Standard genetic approaches allow the production of protein composites by fusion of polypeptides in ...
Historically, bispecific antibodies have been constructed through the genetic fusion of additional b...
Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodi...
Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodi...
<p>We have harnessed two reactions catalyzed by the enzyme sortase A and applied them to generate ne...
ABSTRACT: For many applications, increasing synergy between distinct proteins through organization i...
The transpeptidase, Sortase A is an enzyme that has been used in this function previously ligate eGF...
International audienceFor more than a century, filamentous fungi have been used for the production o...
Understanding the structure and function of protein complexes and multi-domain proteins is highly im...
Diseases are multifactorial, with redundancies and synergies between various pathways. However, most...
Multivalent proteins or protein dendrimers are useful for clinical and biotechnological applications...
A unique two-step modular system for site-specific antibody modification and conjugation is reported...
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical ...
For more than a century, filamentous fungi have been used for the production of a wide variety of en...
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy...
Standard genetic approaches allow the production of protein composites by fusion of polypeptides in ...
Historically, bispecific antibodies have been constructed through the genetic fusion of additional b...
Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodi...
Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodi...
<p>We have harnessed two reactions catalyzed by the enzyme sortase A and applied them to generate ne...
ABSTRACT: For many applications, increasing synergy between distinct proteins through organization i...
The transpeptidase, Sortase A is an enzyme that has been used in this function previously ligate eGF...
International audienceFor more than a century, filamentous fungi have been used for the production o...
Understanding the structure and function of protein complexes and multi-domain proteins is highly im...
Diseases are multifactorial, with redundancies and synergies between various pathways. However, most...
Multivalent proteins or protein dendrimers are useful for clinical and biotechnological applications...
A unique two-step modular system for site-specific antibody modification and conjugation is reported...
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical ...
For more than a century, filamentous fungi have been used for the production of a wide variety of en...
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy...